actionability assessment
Systematic evaluation of whether genomic findings can guide clinical decision-making based on available evidence and therapeutic options.
Full Definition
Actionability assessment is the structured clinical process of determining whether genomic alterations detected in tumor sequencing can meaningfully influence patient management decisions based on current evidence and available therapeutic interventions. This assessment considers multiple factors including the strength of evidence linking the alteration to treatment response, FDA approval status of relevant therapies, clinical trial availability, and patient-specific factors such as performance status and comorbidities. The assessment typically employs standardized frameworks that categorize alterations into tiers based on clinical actionability, from high-confidence therapeutic targets to alterations with limited clinical utility.
Usage
Usage note: Focus on the clinical decision-making aspect rather than just technical variant interpretation.
In Context
- "The actionability assessment identified three genomic alterations with FDA-approved targeted therapies and two with promising clinical trial options." — Molecular tumor board discussion
- "Standardized actionability assessment frameworks ensure consistent interpretation of genomic findings across different institutions." — Laboratory quality guidelines